Methods of treatment associated with the granulocyte colony-stimulating factor receptor
US9962370B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2014 |
| Grant date | May 8, 2018 |
| Priority date | — |
| Expiry date | May 18, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4015
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Some embodiments include methods for treating, preventing, reversing, halting, or slowing the progression of cancer, comprising administering to a subject in need thereof an effective amount of one or more chemotherapeutic agents, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition, wherein at least one of the chemotherapeutic agents is a cytotoxic granulocyte colony-stimulating factor receptor (GCFR) modulator. Methods are also disclosed for treating, preventing, reversing, halting, or slowing the progression of a hematopoietic disorder, comprising administered a therapeutically effective cytotoxic amount of a GCFR modulator to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.